In response to: Dyspnea evaluation after high-dose radiotherapy in patients with NSCLC De Ruysscher et al.

Radiotherapy and Oncology

Volumn 91, Issue 3, 2009, Pages 461-

  Borst, Gerben R ^a   Belderbos, Jose ^a   Burgers, Sjaak ^a   Sonke, Jan Jakob ^a   Lebesque, Joos ^a  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER PATIENT; CANCER RADIOTHERAPY; COMORBIDITY; DYSPNEA; FUNCTIONAL ASSESSMENT; LETTER; LUNG DIFFUSION CAPACITY; LUNG FUNCTION TEST; LUNG NON SMALL CELL CANCER; LUNG PERFUSION; LUNG TOXICITY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION PNEUMONIA; RISK FACTOR; ADULT; AGED; FEMALE; HUMAN; LUNG; LUNG TUMOR; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; NOTE; PATHOPHYSIOLOGY; RADIATION EXPOSURE; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; DEOXYCYTIDINE; DRUG DERIVATIVE; GEMCITABINE; NAVELBINE; VINBLASTINE;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; DYSPNEA; FEMALE; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; RADIOTHERAPY DOSAGE; TREATMENT OUTCOME; VINBLASTINE;

EID: 65649137379     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2009.02.002     Document Type: Letter

References (2)

1. Woel R.T., Munley M.T., Hollis D., Fan M., Bentel G., Anscher M.S., et al. Marks LB: the time course of radiation therapy-induced reductions in regional perfusion: a prospective study with >5 years of follow-up. Int J Radiat Oncol Biol Phys 52 (2002) 58-67
2. Borst G.R., De Jaeger K., Belderbos J.S., Burgers S.A., and Lebesque J.V. Pulmonary function changes after radiotherapy in non-small-cell lung cancer patients with long-term disease-free survival. Int J Radiat Oncol Biol Phys 62 (2005) 639-644